Genetic Insights into Glaucoma 1, Open Angle, O: A New Frontier in Eye Health
Identify glaucoma early with genetic testing. Uncover risk factors, personalize treatments, and optimize management to prevent vision loss and enhance eye health.
Brandon Colby, MD
MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
About Brandon
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Education
- BA in Genetics with Honors, University of Michigan · 2000
- MD, Mount Sinai School of Medicine · 2004
- MBA, Stanford University Graduate School of Business · 2007
Affiliations & Memberships
- Affiliate Specialist, American College of Medical Genetics and Genomics (ACMG)
- Associate, American College of Preventive Medicine (ACPM)
- Member, National Society of Genetic Counselors (NSGC)
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Articles by Brandon
Genetic Insights into Glaucoma 3, Primary Congenital, D: A Pathway to Precision Care
Uncover how genetic testing aids in diagnosing Glaucoma 3, congenital D by identifying mutations, guiding treatment, and informing family planning.
Genetic Insights into Glioma Susceptibility 2: Unlocking the Code to Better Outcomes
Explore how genetic testing for glioma, focusing on MAML2 variants, aids in risk assessment, personalized treatment plans, and prognosis for improved patient care.
Genetic Testing and Glioma Susceptibility 3: Unraveling the DNA Dilemma
Genetic testing uncovers glioma risks by identifying variants like the CYP4F12 SNP. Early detection and personalized treatments enhance patient outcomes.
Genetic Insights into Glioma Susceptibility 7: A New Frontier in Risk Assessment
Uncover how genetic testing identifies variants like MGMT enhancer rs10764901, guiding glioma risk assessment, personalized treatment, and research advancements.
Genetic Testing and Glycogen Storage Disease IXc: A Pathway to Precision Diagnosis
Explore how genetic testing aids in diagnosing Glycogen Storage Disease IXc, guiding treatment, family planning, and advancing research for this rare metabolic disorder.
Harnessing Genetic Testing for Hemochromatosis Type 2B: A Pathway to Early Diagnosis and Prevention
Genetic Gateways: Exploring Hemolytic Anemia Due to Glucophosphate Isomerase Deficiency
Genetic testing unveils mysteries of hemolytic anemia due to glucophosphate isomerase deficiency, aiding diagnosis, guiding family planning, and personalizing treatment.